Olive Lifesciences to pay $2.2 million to Sami-Sabinsa – BioSpectrum
The lawsuit alleged that Olive Lifesciences was selling and distributing products that infringed Sami – Sabinsa’s Curcumin C3 Complex Patent
Sami-Sabinsa Group, the world leader in Curcumin for the dietary supplements industry, has prevailed on all counts in its long-running patent-infringement lawsuit against Olive Lifesciences Pvt. Ltd., which was filed in the United States District Court for the District of New Jersey.
